Can the virus infection of human immunodeficiency virus (HIV) be prevented? This is the question which answer will be searched by the Center for Virology and Biotechnology, Vector, in Russia. The state-funded research center is trying to create a vaccine that can induce strong antibody (antigen).
“We have successfully completed the first phase of clinical trials of HIV vaccines,” said the head of Vector, Alexander Sergeyev. The vaccine is now awaiting approval to test the second stage. (more…)